Recent Finacing
Recent Raise
CytoSeek develops a protein-based membrane augmentation (AMBP) platform that non-genetically augments cell therapies to enhance tumor-killing against solid tumors, pursuing internal programs and out-licensing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
